Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
2023 Global: Diabetic Foot Ulcer Treatment - Innovative Markets Forecast (2029) report
... the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 ... Read More
-
2023 Global: Diabetes Care Devices Market - Innovative Markets Forecast (2029) report
... the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 ... Read More
-
2023 Global: Diabetic Retinopathy Treatment Market - Innovative Markets Forecast (2029) report
... the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 ... Read More
-
2023 Global: Diabetic Nephropathy - Innovative Markets Forecast (2029) report
... 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression analysis in ... Read More
-
2023 Global: Digital Diabetes Management Market - Innovative Markets Forecast (2029) report
... the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 ... Read More
-
2023 Global: Diabetes Therapeutics - Innovative Markets Forecast (2029) report
... 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression analysis in ... Read More
-
2023 Global: Diabetic Macular Edema - Innovative Markets Forecast (2029) report
... 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression ... Read More
-
New Zealand Insulin Drugs and Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)���
... of more than 4%. After COVID-19 was detected, the risk of developing type 1 diabetes increased. The largest risk was in young pediatric and older adult patients with COVID-19. Type 1 diabetic patients were more ... Read More
-
United States Blood Glucose Monitoring Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... forecast period. Diabetic patients were at a higher risk of hospitalizations and complications during the COVID-19 pandemic due to hyper- or hypoglycemia, metabolic comorbidities, and a more severe SARS-CoV-2 infection.The maintenance of euglycemia was important ... Read More
-
New Zealand Diabetes Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... An individual's risk of infection, including other viral infections like the flu, is increased by diabetes. If they get COVID-19, a diabetic patient will likely develop a serious illness and may even pass away. Diabetes ... Read More
-
United Kingdom Self-Monitoring Blood Glucose Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... CAGR of more than 4.8%. The COVID-19 pandemic showed that diabetes needs a lot more attention if we don't want the infection to cause problems that aren't necessary or fair. According to Diabetes UK, in ... Read More
-
New Zealand Self-Monitoring Blood Glucose Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... more than 5.2%. The COVID-19 pandemic showed that diabetes needs a lot more attention if we don't want the infection to cause problems that aren't necessary or fair.All the steps needed to protect this high-risk ... Read More
-
New Zealand Diabetes Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... Type 1 diabetes was more likely to occur after being diagnosed with COVID-19. Young pediatric patients and older adult patients with COVID-19 had the highest risk. Patients with type 1 diabetes were more likely to ... Read More
-
North America Human Insulin Drugs Market - By Product (Human Insulin, Basal Insulin, Bolus Insulin, Insulin Combinations, Biosimilar Insulins); By Application (Product I Diabetes, Product II Diabetes); By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... Landscape & Forecast, 2019–2029 North America Human Insulin Drugs Market Size Grows Steadily to Touch USD 10.3 Billion by 2029 North America human insulin drugs market is flourishing because of an increasing prevalence of type ... Read More
-
India Insulin Pumps Market, By Type (Patch Pumps, Tethered Pumps); By Accessories (Insulin Reservoir or Cartridges, Insulin Set Insertion Devices, Battery); By End Use (Hospitals & Clinics, Homecare, Laboratories); By Region (North India, South India, East India, West India), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... East India, West India), Trend Analysis, Competitive Landscape & Forecast, 2019–2029 India Insulin Pumps Market Size Almost Doubles at Significant CAGR of 10% During 2023–2029 India insulin pumps market is flourishing because of increasing advent ... Read More
-
Patient Engagement Solutions Market Forecasts to 2028 – Global Analysis By Component (Software & Hardware, Services, Other Components), Delivery Mode (Cloud Based, On Premise and Web Based), Therapeutic Area (Chronic Diseases, Diabetes, Obesity, Cardiovascular diseases (CVD), Womens Health, Fitness and Other Therapeutic Areas), Funtionality, Application, End User and By Geography
... (CVD), Womens Health, Fitness and Other Therapeutic Areas), Funtionality, Application, End User and By Geography According to Stratistics MRC, the Global Patient Engagement Solutions Market is accounted for $17.3 billion in 2022 and is expected ... Read More
-
Intravenous Infusion Pump Market - By Product (Volumetric, Syringe, Insulin, Patient-Controlled Analgesia Pump, Ambulatory), By Application (Oncology, Pediatrics/Neonatology, Analgesia/Pain Management, Diabetes, Gastroenterology) By End-use (Hospital & Clinics, Homecare, Ambulatory) & Global Forecast, 2023-2032
... Pumps Market is anticipated to grow considerably during 2023-2032 owing to the increasing product demand in home care settings to limit hospital expenses. Constant technological innovations in intravenous infusion pumps, such as smart infusion pumps, ... Read More
-
Connected Drug Delivery Devices Market - By Device (Connected Sensors, Integrated Devices), By Technology (Bluetooth, Near Field Communication, Wi-Fi), By Application (Anaphylaxis, Respiratory, Cardiovascular, Diabetes, Hormone Replacement), By End-use (Hospital, Clinics, Homecare) & Forecast, 2023 - 2032
... - 2032 Connected Drug Delivery Devices Market is anticipated to garner substantial gains through 2032 owing to the increasing adoption of technologies such as machine learning and artificial intelligence (AI) in healthcare and drug delivery. ... Read More
-
Japan Pharmaceutical Drug Delivery Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Japan market. Also, factors that are driving and restraining the pharmaceutical drug delivery market are highlighted ... Read More
-
Global Insulin Patch Pumps Market Forecast 2023-2032
... of the top drivers bolstering the growth of the market include the rising incidence of diabetes, technological advancements, and surging awareness about patch pumps. MARKET INSIGHTS Insulin patch pumps are efficient devices owing to their ... Read More
-
Indonesia Insulin Patch Pumps Market Forecast 2023-2030
... diabetes and government expenditures to counter it are driving the market growth in the country. MARKET INSIGHTS Insulin patch pumps are advanced digital devices designed to provide regular insulin doses, helping individuals maintain their blood ... Read More
-
Continuous Glucose Monitoring (CGM) Market - Forecasts from 2023 to 2028
... billion by 2028. Continuous glucose monitoring refers to a system used for tracking a person’s blood glucose level throughout the day. It uses a tiny sensor that, when inserted under the skin, does the glucose ... Read More
-
North America Insulin Patch Pumps Market Forecast 2023-2032
... capita income are expected to drive market growth in the region. MARKET INSIGHTS The North America insulin patch pumps market growth assessment includes an analysis of Canada and the United States. Canada boasts a wealth ... Read More
-
In-vitro Diagnostics Market - By Product (Reagents & Kits, Instruments), By Test (Clinical Chemistry, Immunoassay, Hematology, Urinalysis), By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Pharmacogenomics), By End-user (Hospitals, Diagnostic Laboratories) & Forecast, 2023 - 2032
... 2023 - 2032 In-vitro Diagnostics Market is anticipated to grow significantly from 2023 to 2032, owing to the constant improvements in the healthcare infrastructure and the increasing number of government and privately owned pathology labs. ... Read More
-
Europe Insulin Patch Pumps Market Forecast 2023-2032
... of the region is promoted by factors such as the rising prevalence of diabetes, the increase in international research collaborations on technological advancements, as well as the growing awareness about diabetes. MARKET INSIGHTS The Europe ... Read More
Research Assistance
